Mandate

Vinge advises Intera Partners in connection with the investment in Yellow Elk

January 15, 2025

Vinge has advised the Nordic private equity firm Intera Partners in connection with its investment in the AI and data analytics firm Yellow Elk.

Yellow Elk offers high-level expertise within data analytics and AI, spanning from data engineering to machine learning, presentation, analysis and broader advisory, including enterprise and data architecture as well as data-driven change. Founded in 2018, Yellow Elk has a turnover of SEK 150 million and employs around 90 professionals in data and analytics in Sweden. Yellow Elk has been recognized by Dagens Industri as a fast-growing “Gasell” company for the past three years.

The transaction is subject to regulatory approvals.

Vinge’s team consisted of Jonas Johansson, Egil Svensson and Helena Liljenberg (M&A), Helena Göransson and Karl-Gustaw Tobola (Banking and Finance), Mario Saad and Jacob Eberil (Commercial Agreements), Simon Söderholm and Agnes Pigg (Employment), Johan Gavelin (IP), Katja Häglund (IT and GDPR), Madelene Andersson and Sara Franson (Real Estate), Daniel Wendelsson, Martin Hammarskiöld and Lovisa Arpi (Regulatory).

Read the client’s press release.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025